Whalen Wealth Management Inc.
Source: SEC Form 13F · as of Mar 2026Whalen Wealth Management Inc. holds 15 biotech & pharma companies tracked by BioSniper, totaling $11.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$11.3M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 2,353 | $2.2M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 5,247 | $1.4M |
| MRKMerck & Co., Inc. | 8,611 | $1.0M |
| PMPhilip Morris International Inc | 5,685 | $940K |
| NBIXNEUROCRINE BIOSCIENCES INC | 6,462 | $851K |
| JNJJOHNSON & JOHNSON | 3,011 | $736K |
| ABBVAbbVie Inc. | 2,972 | $646K |
| ABTABBOTT LABORATORIES | 5,488 | $563K |
| UTHRUNITED THERAPEUTICS Corp | 849 | $503K |
| INSMINSMED Inc | 2,969 | $485K |
| HALOHALOZYME THERAPEUTICS, INC. | 6,478 | $419K |
| ELANElanco Animal Health Inc | 17,109 | $409K |
| MMSIMerit Medical Systems Inc. | 5,864 | $404K |
| TEVATeva Pharmaceutical Industries Limited | 12,480 | $376K |
| ELVElevance Health Inc. | 1,064 | $311K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.